Apollon Wealth Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
Apollon Wealth Management's IBRX Position: Q3 2026 in Review
Apollon Wealth Management reduced its ImmunityBio (IBRX) stake by 4.8% in Q3 2026, selling an estimated $5.72K and leaving 14,152 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #1561.
Apollon Wealth Management first reported a position in IBRX in Q1 2023 and has held it in 3 quarters since. 407 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.
- Apollon Wealth Management held 14,152 shares of ImmunityBio worth $134K as of Q3 2026.
- Apollon Wealth Management sold 715 ImmunityBio shares in Q3 2026, an estimated $5.72K.
- ImmunityBio made up ﹤0.01% of Apollon Wealth Management's portfolio in Q3 2026, its #1561 holding.
- Apollon Wealth Management first reported a position in ImmunityBio in Q1 2023 and has held it in 3 quarters since.
- 407 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.
Based on Apollon Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.